473 related articles for article (PubMed ID: 29157619)
1. Diagnosis of Castleman Disease.
Szalat R; Munshi NC
Hematol Oncol Clin North Am; 2018 Feb; 32(1):53-64. PubMed ID: 29157619
[TBL] [Abstract][Full Text] [Related]
2. Castleman Disease.
Wang W; Medeiros LJ
Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
[TBL] [Abstract][Full Text] [Related]
3. The Peripheral Neuropathies of POEMS Syndrome and Castleman Disease.
Mauermann ML
Hematol Oncol Clin North Am; 2018 Feb; 32(1):153-163. PubMed ID: 29157616
[TBL] [Abstract][Full Text] [Related]
4. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.
Lyapichev KA; You MJ; Vega F; Solis LM; Medeiros LJ
Virchows Arch; 2020 Sep; 477(3):437-444. PubMed ID: 32152665
[TBL] [Abstract][Full Text] [Related]
5. Pathology of Castleman Disease.
Wu D; Lim MS; Jaffe ES
Hematol Oncol Clin North Am; 2018 Feb; 32(1):37-52. PubMed ID: 29157618
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum of Castleman disease-associated neuropathy.
Naddaf E; Dispenzieri A; Mandrekar J; Mauermann ML
Neurology; 2016 Dec; 87(23):2457-2462. PubMed ID: 27807187
[TBL] [Abstract][Full Text] [Related]
7. Castleman disease and TAFRO syndrome.
Masaki Y; Arita K; Sakai T; Takai K; Aoki S; Kawabata H
Ann Hematol; 2022 Mar; 101(3):485-490. PubMed ID: 35044513
[TBL] [Abstract][Full Text] [Related]
8. Borderline Case of TAFRO Syndrome and POEMS Syndrome.
Shibata S; Tabata S; Morita H; Endo T; Kawasaki N; Okamoto Y; Inano S; Takiuchi Y; Fukunaga A; Kitano T
Intern Med; 2021 May; 60(10):1589-1595. PubMed ID: 33328401
[TBL] [Abstract][Full Text] [Related]
9. From Castleman disease histopathological features to idiopathic multicentric Castleman disease: a multiparametric approach to exclude potential iMCD histopathological mimickers.
Rodriguez Merino L; Pomares AA; Arce JR; Montes-Moreno S
J Clin Pathol; 2024 Apr; 77(5):318-323. PubMed ID: 36690434
[TBL] [Abstract][Full Text] [Related]
10. The management of Castleman disease.
Lomas OC; Streetly M; Pratt G; Cavet J; Royston D; Schey S; Ramasamy K;
Br J Haematol; 2021 Nov; 195(3):328-337. PubMed ID: 34340261
[No Abstract] [Full Text] [Related]
11. Multicentric Castleman disease: Where are we now?
Wang HW; Pittaluga S; Jaffe ES
Semin Diagn Pathol; 2016 Sep; 33(5):294-306. PubMed ID: 27296355
[TBL] [Abstract][Full Text] [Related]
12. Castleman disease.
Carbone A; Borok M; Damania B; Gloghini A; Polizzotto MN; Jayanthan RK; Fajgenbaum DC; Bower M
Nat Rev Dis Primers; 2021 Nov; 7(1):84. PubMed ID: 34824298
[TBL] [Abstract][Full Text] [Related]
13. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
Menke DM; Tiemann M; Camoriano JK; Chang SF; Madan A; Chow M; Habermann TM; Parwaresch R
Am J Clin Pathol; 1996 Mar; 105(3):268-76. PubMed ID: 8602606
[TBL] [Abstract][Full Text] [Related]
15. Multicentric Castleman disease and the evolution of the concept.
Zhou T; Wang HW; Pittaluga S; Jaffe ES
Pathologica; 2021 Oct; 113(5):339-353. PubMed ID: 34837092
[TBL] [Abstract][Full Text] [Related]
16. Historical and pathological overview of Castleman disease.
Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
J Clin Exp Hematop; 2022 Jun; 62(2):60-72. PubMed ID: 35474035
[TBL] [Abstract][Full Text] [Related]
17. [Not Available].
Galicier L; Schleinitz N
Rev Med Interne; 2022 Dec; 43(10S1):10S26-10S33. PubMed ID: 36657940
[TBL] [Abstract][Full Text] [Related]
18. [Castleman disease. Histopathological and immunohistochemical analysis of 39 cases].
Sevilla-Lizcano DB; Frias-Soria CL; Ortiz-Hidalgo C
Gac Med Mex; 2017; 153(5):550-558. PubMed ID: 29099112
[TBL] [Abstract][Full Text] [Related]
19. The clinical spectrum of Castleman's disease.
Dispenzieri A; Armitage JO; Loe MJ; Geyer SM; Allred J; Camoriano JK; Menke DM; Weisenburger DD; Ristow K; Dogan A; Habermann TM
Am J Hematol; 2012 Nov; 87(11):997-1002. PubMed ID: 22791417
[TBL] [Abstract][Full Text] [Related]
20. A Rare Lymphoproliferative Disease: Castleman Disease.
Gündüz E; Özdemir N; Bakanay ŞM; Karakuş S
Turk J Haematol; 2021 Dec; 38(4):314-320. PubMed ID: 34719151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
